F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 35.9 SEK 1.99% Market Closed
Market Cap: 489m SEK
Have any thoughts about
Fluoguide AS?
Write Note

Fluoguide AS
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fluoguide AS
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluoguide AS
STO:FLUO
Capital Expenditures
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Capital Expenditures
-kr220m
CAGR 3-Years
-1%
CAGR 5-Years
14%
CAGR 10-Years
-32%
Zealand Pharma A/S
CSE:ZEAL
Capital Expenditures
-kr20.5m
CAGR 3-Years
-144%
CAGR 5-Years
-5%
CAGR 10-Years
-13%
Ascendis Pharma A/S
NASDAQ:ASND
Capital Expenditures
-€981k
CAGR 3-Years
66%
CAGR 5-Years
28%
CAGR 10-Years
1%
B
Bavarian Nordic A/S
CSE:BAVA
Capital Expenditures
-kr1.1B
CAGR 3-Years
-36%
CAGR 5-Years
-27%
CAGR 10-Years
-21%
Bioporto A/S
CSE:BIOPOR
Capital Expenditures
-kr39k
CAGR 3-Years
71%
CAGR 5-Years
51%
CAGR 10-Years
26%
No Stocks Found

Fluoguide AS
Glance View

Market Cap
445.5m SEK
Industry
Biotechnology

FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.

FLUO Intrinsic Value
38.97 SEK
Undervaluation 8%
Intrinsic Value
Price
F

See Also

What is Fluoguide AS's Capital Expenditures?
Capital Expenditures
0 DKK

Based on the financial report for Dec 31, 2023, Fluoguide AS's Capital Expenditures amounts to 0 DKK.

Back to Top